Latest Clinical trial Stories
Data expected to be released in Q1 2015 PETACH TIKVA, Israel, Feb.
LONDON, February 4, 2015 /PRNewswire/ -- Report Details Supporting clinical trials - discover that industry's latest trends, news and revenue potentials What
GLEN BURNIE, Md., Feb.
In the news release, BrainStorm Announces Positive DSMB Recommendation in Ongoing Phase 2 Trial with NurOwn(TM) in ALS, issued Feb. 3, 2015 by BrainStorm Cell Therapeutics Inc.
- Array to regain worldwide rights to binimetinib and receive worldwide rights to encorafenib - BOULDER, Colo., Feb.
SAN DIEGO, Feb. 3, 2015 /PRNewswire/ -- Mast Therapeutics, Inc.
No Concerns Identified; DSMB Recommends Trial Continues as Planned HACKENSACK, N.J. and PETACH TIKVAH, Israel, Feb.
-- Approval triggers $3.0 million milestone payment -- SAN DIEGO, Feb. 3, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
LOS ANGELES, Feb.
TOKYO, Feb. 2, 2015 /PRNewswire/ -- Astellas Pharma Inc.
- A political dynamiter.